Allworth Financial LP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40,870
+16.0%
901
+4.9%
0.00%
Q2 2023$35,245
+24.4%
859
+8.3%
0.00%
Q1 2023$28,342
-5.8%
793
-0.5%
0.00%
Q4 2022$30,103
-14.0%
7970.0%0.00%
Q3 2022$35,000
+29.6%
797
+7.8%
0.00%
Q2 2022$27,0000.0%7390.0%0.00%
Q1 2022$27,000
+22.7%
739
+1.1%
0.00%
Q4 2021$22,000
+2100.0%
731
+4200.0%
0.00%
Q3 2021$1,0000.0%170.0%0.00%
Q2 2021$1,0000.0%170.0%0.00%
Q1 2021$1,0000.0%170.0%0.00%
Q4 2020$1,0000.0%170.0%0.00%
Q3 2020$1,0000.0%170.0%0.00%
Q2 2020$1,0000.0%17
-29.2%
0.00%
Q1 2020$1,0000.0%240.0%0.00%
Q4 2019$1,00024
+242.9%
0.00%
Q3 2019$070.0%0.00%
Q2 2019$0
-100.0%
70.0%0.00%
Q1 2019$1,0000.0%7
-75.9%
0.00%
Q1 2018$1,000290.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders